Skip to main content
Premium Trial:

Request an Annual Quote

David Lasecki

GenomOncology has appointed David Lasecki as chief commercialization officer. In this position, Lasecki will lead the company's growth strategy by working with key stakeholders in the healthcare industry to promote the widespread adoption of precision medicine. Most recently, he served as president of CompanionDx Labs and additionally presided over the commercialization of CompanionDx's oncology-specific DNA sequencing and pharmacogenomics tests. Lasecki has also held a variety of sales and new business development roles with AmerisourceBergen's specialty group, the International Oncology Network.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.